Marlborough, United States
Boston Scientific, founded in 2008, is a prominent player in the Health Care and Medical Devices industries, headquartered in the United States. With over four decades of leadership, the company is renowned for developing medical technologies that not only transform patient lives but also reduce healthcare costs.
Boston Scientific's slogan, "We work collaboratively to solve healthcare’s toughest problems by developing solutions that matter most to those suffering from debilitating conditions," encapsulates their mission to address complex diseases across various medical fields, including cardiovascular, respiratory, and neurological domains.
Recently, Boston Scientific secured an impressive $11.00B in post-IPO debt investment as of 01 February 2026. This capital infusion is expected to bolster their expansive portfolio and drive further innovations. While details of the investors remain undisclosed, the significant funding highlights strong confidence in the company’s vision and growth trajectory.
